Quanterix Corp QTRX
News
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quanterix Names Dr. Yuri Fesko Chief Medical Officer
Quanterix Names Jim Gute Chief Commercial Officer
Quanterix Releases Financial Results for the Second Quarter of 2026
Quanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12
Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026
Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages